Your session is about to expire
← Back to Search
Roflumilast for Asthma
Study Summary
This trial will test whether or not roflumilast can help asthmatics who are obese and have low levels of a certain receptor respond better to β2 adrenoreceptor agonists.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 12 Patients • NCT03073798Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
What potential risks might patients taking Roflumilast be exposed to?
"The safety of Roflumilast is rated a 1 on the scale due to its Phase 1 status, meaning there are limited studies that attest to both efficacy and safety."
What is the maximum number of participants being enrolled in this research endeavor?
"Affirmative. Clinicaltrials.gov's publicly accessible data implies that this medical investigation is currently in the process of recruitment, which began on January 21st 2019 and was most recently amended on January 31st 2022. Approximately 24 patients must be drawn from a single trial site for participation."
Are there currently open opportunities for volunteers to join this study?
"According to the clinicaltrials.gov website, this medical study is in active recruitment mode and has been since it was first posted on January 21st 2019 with edits occurring as recently as January 31st 2022."
What other researches have been conducted to assess the efficacy of Roflumilast?
"Presently, there are 9 ongoing clinical trials exploring Roflumilast with 3 at the Phase 3 level. Although most of these studies occur in Shibeen Elkom and Menoufia, there are 121 different research facilities involved."
Share this study with friends
Copy Link
Messenger